0001104659-19-005605.txt : 20190204
0001104659-19-005605.hdr.sgml : 20190204
20190204183515
ACCESSION NUMBER: 0001104659-19-005605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190131
FILED AS OF DATE: 20190204
DATE AS OF CHANGE: 20190204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARPENTER CHRISTOPHER L.
CENTRAL INDEX KEY: 0001746845
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 19565636
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS
STREET 2: 325 VASSAR ST., SUITE 1A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 VASSAR STREET, SUITE 1A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 325 VASSAR STREET, SUITE 1A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2019-01-31
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001746845
CARPENTER CHRISTOPHER L.
C/O RUBIUS THERAPEUTICS, INC.
325 VASSAR STREET, SUITE 1A
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
13.69
2019-01-31
4
A
0
100000
0
A
2029-01-30
Common Stock
100000
100000
D
25% of this option shall vest on January 31, 2020, then in 12 equal quarterly installments thereafter.
/s/ Joanne M. Protano, Attorney-in-Fact
2019-02-04